Literature DB >> 12658490

Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis.

Miin-Fu Chen1, Hsiu-Pei Tsai, Long-Bin Jeng, Wei-Chen Lee, Chun-Nan Yeh, Ming-Chin Yu, Chao-Ming Hung.   

Abstract

The aim of this study was to investigate the prognostic factors for hepatocellular carcinoma (HCC) in patients without cirrhosis who underwent hepatectomy. Between 1986 and 1998 a total of 197 men and 57 women with noncirrhotic HCC underwent hepatic resection in the Department of Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan. We determined their surgical mortality and the disease-free and overall cumulative survival rates. The surgical mortality was 4.7% and the 5-year disease-free survival rate 24.01%. By Cox regression analysis, serum alkaline phosphatase [relative risk (RR) 1.761; 95% confidence interval (CI) 1.037-2.985)], albumin (RR 2.179; CI 1.215-3.908), multiple tumor status (RR 2.288; CI 1.272-4.115), and blood urea nitrogen (RR 4.651; CI 1.116-19.38) were shown to be independent prognostic factors for the 5-year disease-free survival rates. The 5-year overall cumulative survival rate was 25.91%. By Cox regression analysis, serum albumin (RR 1.656, CI 1.005-2.730), blood transfusion (RR 2.075, CI 1.153-3.731), resection margin (RR 2.562, CI 1.436-4.572), and multiple tumors (RR 2.801, CI 1.727-4.545) were shown to be significant independent factors that influenced cumulative survival rates. Hence in patients with a noncirrhotic HCC who underwent hepatectomy the prognosis depended on preoperative hepatic function, the presence of multiple tumors, the need for blood transfusion, and the surgical resection margin.

Entities:  

Mesh:

Year:  2003        PMID: 12658490     DOI: 10.1007/s00268-002-6708-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

1.  Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis.

Authors:  Zhao-Ru Dong; Peng-Fei Zhang; Cheng-Hao Wang; Chi Zhang; Jia-Bin Cai; Guo-Ming Shi; Ai-Wu Ke; Hui-Chuan Sun; Shuang-Jian Qiu; Jian Zhou; Jia Fan
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 2.  [Liver resection and transplantation for hepatic tumors].

Authors:  H Lang; C E Broelsch
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

3.  Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma.

Authors:  Manabu Morimoto; Kazushi Numata; Kazuya Sugimori; Kazuhito Shirato; Atsushi Kokawa; Hiroyuki Oka; Kingo Hirasawa; Ryonho Koh; Hiromi Nihommatsu; Katsuaki Tanaka
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

4.  Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis.

Authors:  Dean J Arnaoutakis; Michael N Mavros; Feng Shen; Sorin Alexandrescu; Amin Firoozmand; Irinel Popescu; Matthew Weiss; Christopher L Wolfgang; Michael A Choti; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2014-01       Impact factor: 5.344

5.  A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort.

Authors:  Tian Yang; Jin Zhang; Jun-Hua Lu; Li-Qun Yang; Guang-Shun Yang; Meng-Chao Wu; Wei-Feng Yu
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-06       Impact factor: 4.553

6.  Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence?

Authors:  Ming-Chin Yu; Kun-Ming Chan; Chen-Fang Lee; Yun-Shien Lee; Firas Zahr Eldeen; Hong-Shiue Chou; Wei-Chen Lee; Miin-Fu Chen
Journal:  J Gastrointest Surg       Date:  2011-05-04       Impact factor: 3.452

7.  Recurrence of hepatocellular carcinoma in noncirrhotic liver after hepatectomy.

Authors:  Laurence Chiche; B Menahem; C Bazille; V Bouvier; L Plard; V Saguet; A Alves; E Salame
Journal:  World J Surg       Date:  2013-10       Impact factor: 3.352

8.  Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy.

Authors:  Chun-Nan Yeh; Ta-Sen Yeh; Tse-Ching Chen; Yi-Yin Jan; Miin-Fu Chen
Journal:  J Gastroenterol       Date:  2012-09-25       Impact factor: 7.527

9.  Clinical characteristics and survival of European patients with resectable large hepatocellular carcinomas.

Authors:  Felice Giuliante; Agostino Maria De Rose; Vito Guerra; Francesco Ardito; Gennaro Nuzzo; Brian I Carr
Journal:  J Gastrointest Cancer       Date:  2013-09

10.  Anatomical Resection But Not Surgical Margin Width Influence Survival Following Resection for HCC, A Propensity Score Analysis.

Authors:  Jung-Woo Lee; Young-Joo Lee; Kwang-Min Park; Dae-Wook Hwang; Jae Hoon Lee; Ki Byung Song
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.